Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples

Pancreatology - Tập 12 - Trang 27-34 - 2012
B. Bournet1,2, A. Pointreau1,2, A. Souque1, N. Oumouhou3, F. Muscari1,2, B. Lepage3, P. Senesse4, M. Barthet5, N. Lesavre5, P. Hammel6, P. Levy6, P. Ruszniewski6, P. Cordelier1, L. Buscail1,2
1INSERM UMR1037, Cancer Research Center of Toulouse, CHU Rangueil, 1 avenue Jean Poulhès, Bât. L3, BP 84225, 31432 Toulouse Cedex 4, France
2Department of Gastroenterology, University of Toulouse, CHU Rangueil, Toulouse, France
3INSERM U558, University of Toulouse, School of Medicine Purpan, Toulouse, France
4Department of Oncology, Val d’Aurelle Center, Montpellier, France
5Department of Gastroenterology and Center for Clinical Investigation, CHU Nord, Marseille, France
6Department of Gastroenterology and Pancreatology, Beaujon Hospital, Clichy, France

Tài liệu tham khảo

Warshaw, 1992, Pancreatic carcinoma, N Eng J Med, 326, 455, 10.1056/NEJM199202133260706 Bournet, 2009, Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis, Endoscopy, 41, 552, 10.1055/s-0029-1214717 Wiersema, 2001, Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma, Pancreatology, 1, 625, 10.1159/000055872 Buscail, 2006, Interventional endoscopic ultrasound in pancreatic diseases, Pancreatology, 6, 7, 10.1159/000090022 Bhutani, 2005, Endoscopic ultrasound-guided fine-needle aspiration cytology for diagnosis above and below the diaphragm, J Clin Ultrasound, 33, 401, 10.1002/jcu.20149 Torrisani, 2009, Let-7 microRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression, Hum Gene Ther, 20, 831, 10.1089/hum.2008.134 Crnogorac-Jurcevic, 2001, Gene expression profiles of pancreatic cancer and stromal desmoplasia, Oncogene, 20, 7437, 10.1038/sj.onc.1204935 Iacobuzio-Donahue, 2002, Discovery of novel tumor markers of pancreatic cancer using global gene expression technology, Am J Pathol, 160, 1239, 10.1016/S0002-9440(10)62551-5 Logsdon, 2003, Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer, Cancer Res, 63, 2649 Sato, 2003, Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma, Cancer Res, 63, 4158 Crnogorac-Jurcevic, 2003, Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent, J Pathol, 201, 63, 10.1002/path.1418 Laurell, 2006, Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples, World J Gastroenterol, 12, 3344, 10.3748/wjg.v12.i21.3344 Friess, 2001, Identification of disease-specific genes in chronic pancreatitis using DNA array technology, Ann Surg, 234, 769, 10.1097/00000658-200112000-00008 Iacobuzio-Donahue, 2003, Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays, Am J Pathol, 162, 1151, 10.1016/S0002-9440(10)63911-9 Ramachandran, 2007, Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR, Cancer Res, 67, 2666, 10.1158/0008-5472.CAN-06-3362 Niedergethmann, 2007, Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model, Br J Cancer, 97, 1432, 10.1038/sj.bjc.6604031 Sarbia, 2007, Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful?, Am J Clin Pathol, 128, 255, 10.1309/EEML5CH79PWD0R2D Bramhall, 1996, Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease, Br J Cancer, 73, 972, 10.1038/bjc.1996.190 Bharadwaj, 2008, Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3, Mol Cancer Res, 6, 1755, 10.1158/1541-7786.MCR-08-0095 Missiaglia, 2004, Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis, Int J Cancer, 112, 100, 10.1002/ijc.20376 Whiteman, 2007, The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D, Cancer Res, 67, 8633, 10.1158/0008-5472.CAN-07-0545 Guweidhi, 2004, Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis, Carcinogenesis, 25, 1575, 10.1093/carcin/bgh159 Shi, 1997, A structural basis for mutational inactivation of the tumour suppressor Smad4, Nature, 388, 87, 10.1038/40431 Buscail, 1996, Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer, Cancer Res, 56, 1823 Suehara, 1997, Telomerase elevation in pancreatic ductal carcinoma compared to non-malignant pathological states, Clin Cancer Res, 3, 993 Hayer, 2003, Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis, Nature, 425, 851, 10.1038/nature02009 Goulter, 2006, Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue, BMC Genomics, 7, 34, 10.1186/1471-2164-7-34 Steg, 2006, Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma, J Mol Diagn, 8, 76, 10.2353/jmoldx.2006.040402 Paciucci, 1998, The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro, Oncogene, 16, 625, 10.1038/sj.onc.1201564 Diaz, 2002, Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells, Gastroenterology, 122, 806, 10.1053/gast.2002.31885 Nielsen, 2005, Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction, J Gastroenterol Hepatol, 20, 256, 10.1111/j.1440-1746.2004.03531.x Harvey, 2003, Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer, Clin Cancer Res, 9, 4935 Jones, 2004, Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival, Clin Cancer Res, 10, 2832, 10.1158/1078-0432.CCR-1157-03 Chen, 2007, Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration, Int J Cancer, 120, 1511, 10.1002/ijc.22487